BeiGene Ltd (BGNE)
191.26
-3.30
(-1.69%)
USD |
NASDAQ |
Nov 22, 09:55
BeiGene Total Assets (Quarterly): 5.831B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.831B |
| June 30, 2024 | 5.712B |
| March 31, 2024 | 5.668B |
| December 31, 2023 | 5.805B |
| September 30, 2023 | 5.525B |
| June 30, 2023 | 5.729B |
| March 31, 2023 | 5.957B |
| December 31, 2022 | 6.379B |
| September 30, 2022 | 6.726B |
| June 30, 2022 | 7.378B |
| March 31, 2022 | 8.021B |
| December 31, 2021 | 8.536B |
| September 30, 2021 | 5.286B |
| June 30, 2021 | 5.524B |
| March 31, 2021 | 5.821B |
| December 31, 2020 | 5.601B |
| September 30, 2020 | 5.566B |
| June 30, 2020 | 3.903B |
| March 31, 2020 | 4.067B |
| December 31, 2019 | 1.612B |
| Date | Value |
|---|---|
| September 30, 2019 | 1.881B |
| June 30, 2019 | 2.150B |
| March 31, 2019 | 2.172B |
| December 31, 2018 | 2.250B |
| September 30, 2018 | 2.409B |
| June 30, 2018 | 1.654B |
| March 31, 2018 | 1.709B |
| December 31, 2017 | 1.046B |
| September 30, 2017 | 1.049B |
| June 30, 2017 | 473.98M |
| March 31, 2017 | 376.73M |
| December 31, 2016 | 405.81M |
| September 30, 2016 | 235.42M |
| June 30, 2016 | 251.23M |
| March 31, 2016 | 265.23M |
| December 31, 2015 | 116.76M |
| September 30, 2015 | 135.61M |
| June 30, 2015 | 136.96M |
| December 31, 2014 | 53.62M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.612B
Minimum
Dec 2019
8.536B
Maximum
Dec 2021
5.732B
Average
5.720B
Median
Total Assets (Quarterly) Benchmarks
| Theravance Biopharma Inc | 356.10M |
| Merck & Co Inc | 117.53B |
| Bristol-Myers Squibb Co | 93.67B |
| Zai Lab Ltd | 985.35M |
| Halozyme Therapeutics Inc | 2.118B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.395B |
| Shareholders Equity (Quarterly) | 3.436B |
| Debt to Equity Ratio | 0.306 |
| Current Ratio | 1.931 |
| Net Debt Paydown Yield | -0.35% |